These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31581917)

  • 1. Renal targeting delivery systems.
    Yuan ZX; Shang Z; Gu J; He L
    Future Med Chem; 2019 Sep; 11(17):2237-2240. PubMed ID: 31581917
    [No Abstract]   [Full Text] [Related]  

  • 2. Disassembly of amphiphilic small molecular prodrug with fluorescence switch induced by pH and folic acid receptors for targeted delivery and controlled release.
    Xu Z; Shi X; Hou M; Xue P; Gao YE; Liu S; Kang Y
    Colloids Surf B Biointerfaces; 2017 Feb; 150():50-58. PubMed ID: 27883931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin-doxorubicin conjugate prodrug as drug self-delivery system for intracellular pH-triggered slow release.
    Li J; Li X; Liu P
    Colloids Surf B Biointerfaces; 2020 Jan; 185():110608. PubMed ID: 31707225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabrication of Cellulose-Nanocrystal-Based Folate Targeted Nanomedicine via Layer-by-Layer Assembly with Lysosomal pH-Controlled Drug Release into the Nucleus.
    Li N; Zhang H; Xiao Y; Huang Y; Xu M; You D; Lu W; Yu J
    Biomacromolecules; 2019 Feb; 20(2):937-948. PubMed ID: 30621397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dual-targeting strategy for enhanced drug delivery and synergistic therapy based on thermosensitive nanoparticles.
    Wang M; You C; Gao Z; Wu H; Sun B; Zhu X; Chen R
    J Biomater Sci Polym Ed; 2018 Aug; 29(11):1360-1374. PubMed ID: 29611463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mussel-Derived, Cancer-Targeting Peptide as pH-Sensitive Prodrug Nanocarrier.
    Ma Y; He P; Tian X; Liu G; Zeng X; Pan G
    ACS Appl Mater Interfaces; 2019 Jul; 11(27):23948-23956. PubMed ID: 31192575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of molecular structure on the anticancer drug release rate from prodrug nanoparticles.
    Ikuta Y; Koseki Y; Onodera T; Oikawa H; Kasai H
    Chem Commun (Camb); 2015 Aug; 51(64):12835-8. PubMed ID: 26165183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of folic acid through liquid-crystalline folate nanoparticles.
    Misra R; Katyal H; Mohanty S
    Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():352-61. PubMed ID: 25280715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-Cross-Linked Hyaluronic Acid Nanoparticles with pH/Reduction Dual-Responsive Triggered Release and pH-Modulated Fluorescence for Folate-Receptor-Mediated Targeting Visualized Chemotherapy.
    Zhao X; Jia X; Liu L; Zeng J; Tian K; Zhou T; Liu P
    Biomacromolecules; 2016 Apr; 17(4):1496-505. PubMed ID: 27010934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial of Special Issue "Surface-Functionalized Nanoparticles as Drug Carriers".
    Layek B; Singh J
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
    Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
    Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer-targeted delivery of oxaliplatin via folic acid-grafted solid lipid nanoparticles: preparation, optimization, and in vitro evaluation.
    Rajpoot K; Jain SK
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1236-1247. PubMed ID: 28849671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Click and release: bioorthogonal approaches to "on-demand" activation of prodrugs.
    Ji X; Pan Z; Yu B; De La Cruz LK; Zheng Y; Ke B; Wang B
    Chem Soc Rev; 2019 Feb; 48(4):1077-1094. PubMed ID: 30724944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cargo-encapsulated cells for drug delivery.
    Chen Z; Wen D; Gu Z
    Sci China Life Sci; 2020 Apr; 63(4):599-601. PubMed ID: 32146697
    [No Abstract]   [Full Text] [Related]  

  • 16. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency.
    Lin MH; Hung CF; Hsu CY; Lin ZC; Fang JY
    Future Med Chem; 2019 Aug; 11(16):2131-2150. PubMed ID: 31538520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of insulin from folic acid-insulin complex nanoparticles.
    Gupta R; Mohanty S
    Colloids Surf B Biointerfaces; 2017 Jun; 154():48-54. PubMed ID: 28288342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained-release microparticle dry powders of chloramphenicol palmitate or thiamphenicol palmitate prodrugs for lung delivery as aerosols.
    Nurbaeti SN; Brillault J; Tewes F; Olivier JC
    Eur J Pharm Sci; 2019 Oct; 138():105028. PubMed ID: 31377132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems.
    Narmani A; Rezvani M; Farhood B; Darkhor P; Mohammadnejad J; Amini B; Refahi S; Abdi Goushbolagh N
    Drug Dev Res; 2019 Jun; 80(4):404-424. PubMed ID: 31140629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.